William P Forbes insider trades: Heron Therapeutics (HRTX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where William reports to the SEC
Open-market buys and sales
23 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 17, 2023 | HRTX | ↑ Buy | 25,000 | $1.09 | $27K | Direct | Nov 21, 2023 (4d) |
| Nov 16, 2023 | HRTX | ↑ Buy | 50,000 | $0.94 | $47K | Direct | Nov 20, 2023 (4d) |
| Mar 31, 2023 | XAIR | ↑ Buy | 5,000 | $6.67 | $33K | Direct | Apr 3, 2023 (3d) |
| Mar 17, 2023 | XAIR | ↑ Buy | 5,000 | $6.46 | $32K | Direct | Mar 20, 2023 (3d) |
| Jun 3, 2019 | XAIR | ↑ Buy | 4,855 | $5.15 | $25K | Direct | Nov 15, 2019 (165d) |
| Mar 9, 2015 | SLXP | ↓ Sell | 42,880 | $157.84 | $6.8M | Direct | Mar 11, 2015 (2d) |
| Mar 6, 2015 | SLXP | ↓ Sell | 20,000 | $157.96 | $3.2M | Direct | Mar 9, 2015 (3d) |
| Nov 12, 2014 | SLXP | ↓ Sell | 11,079 | $95.05 | $1.1M | Direct | Nov 14, 2014 (2d) |
| Jan 8, 2014 | SLXP | ↓ Sell | 8,000 | $90.06 | $720K | Direct | Jan 10, 2014 (2d) |
| Jul 24, 2013 | SLXP | ↓ Sell | 12,000 | $70.93 | $851K | Direct | Jul 26, 2013 (2d) |
| Apr 10, 2013 | SLXP | ↓ Sell | 8,673 | $49.37 | $428K | Direct | Apr 12, 2013 (2d) |
| May 8, 2012 | SLXP | ↓ Sell | 10,000 | $51.61 | $516K | Direct | May 21, 2012 (13d) |
| Feb 13, 2012 | SLXP | ↓ Sell | 4,297 | $50.00 | $215K | Direct | Feb 15, 2012 (2d) |
| Feb 3, 2012 | SLXP | ↓ Sell | 259 | $50.00 | $13K | Direct | Feb 7, 2012 (4d) |
| Jan 18, 2012 | SLXP | ↓ Sell | 1,244 | $50.05 | $62K | Direct | Jan 19, 2012 (1d) |
| Jul 7, 2011 | SLXP | ↓ Sell | 13,000 | $39.60 | $515K | Direct | Jul 11, 2011 (4d) |
| May 16, 2011 | SLXP | ↓ Sell | 20,000 | $40.35 | $807K | Direct | May 18, 2011 (2d) |
| Nov 10, 2010 | SLXP | ↓ Sell | 10,000 | $40.01 | $400K | Direct | Nov 12, 2010 (2d) |
| Sep 15, 2010 | SLXP | ↓ Sell10b5-1 | 10,695 | $40.50 | $433K | Direct | Sep 16, 2010 (1d) |
| Apr 14, 2010 | SLXP | ↓ Sell | 10,000 | $40.03 | $400K | Direct | Apr 16, 2010 (2d) |
| Apr 1, 2010 | SLXP | ↓ Sell | 1,879 | $38.00 | $71K | Direct | Apr 5, 2010 (4d) |
| Dec 23, 2009 | SLXP | ↓ Sell | 5,000 | $25.00 | $125K | Direct | Dec 28, 2009 (5d) |
| Jul 3, 2007 | SLXP | ↓ Sell | 1,113 | $12.33 | $14K | Direct | Jul 6, 2007 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About William P Forbes's insider trades
William P Forbes is EVP, Chief Development Officer at Heron Therapeutics (HRTX). Since Jul 3, 2007, William has reported 5 open-market purchases worth $165K and 18 sales worth $16.6M on SEC Form 4. There have been no open-market trades in the last 12 months.
1 sale (3% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include option exercises (31 filings), grants and awards (23 filings), shares withheld for taxes (15 filings), shares returned to the company (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every HRTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.